Oncolytic viruses move forward in clinical trials.

Journal of the National Cancer Institute

Volumn 102, Issue 9, 2010, Pages 590-595

  Rowan, Karen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ONCOLYTIC VIRUS;

CLINICAL TRIAL; GENE EXPRESSION REGULATION; HUMAN; MEASLES VIRUS; METHODOLOGY; NEOPLASM; NOTE; ONCOLYTIC VIROTHERAPY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL;

CLINICAL TRIALS AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; HUMANS; MEASLES VIRUS; NEOPLASMS; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES;

EID: 77952311664     PISSN: None     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djq165     Document Type: Note

References (0)